Zuben E. Sauna

11.3k total citations · 3 hit papers
115 papers, 8.0k citations indexed

About

Zuben E. Sauna is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Zuben E. Sauna has authored 115 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 40 papers in Oncology and 32 papers in Hematology. Recurrent topics in Zuben E. Sauna's work include Drug Transport and Resistance Mechanisms (33 papers), Hemophilia Treatment and Research (27 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Zuben E. Sauna is often cited by papers focused on Drug Transport and Resistance Mechanisms (33 papers), Hemophilia Treatment and Research (27 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Zuben E. Sauna collaborates with scholars based in United States, India and Germany. Zuben E. Sauna's co-authors include Suresh V. Ambudkar, Chava Kimchi‐Sarfaty, Michael M. Gottesman, In‐Wha Kim, Jung Mi Oh, Anna Maria Calcagno, Vijaya L. Simhadri, Ryan Hunt, Marianna Müller and Amy S. Rosenberg and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Zuben E. Sauna

111 papers receiving 7.8k citations

Hit Papers

A "Silent" Polymorphism i... 2003 2026 2010 2018 2006 2003 2011 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zuben E. Sauna 4.3k 3.1k 1.0k 890 841 115 8.0k
Chava Kimchi‐Sarfaty 3.3k 0.8× 1.6k 0.5× 1.1k 1.1× 524 0.6× 588 0.7× 88 6.0k
Melissa H. Wong 3.3k 0.8× 2.5k 0.8× 721 0.7× 407 0.5× 351 0.4× 88 6.7k
Rando Allikmets 9.1k 2.1× 2.6k 0.9× 1.0k 1.0× 1.1k 1.2× 417 0.5× 213 14.9k
Clifford J. Steer 8.1k 1.9× 2.4k 0.8× 1.0k 1.0× 405 0.5× 420 0.5× 276 13.6k
Mong‐Hong Lee 6.7k 1.6× 3.6k 1.2× 1.1k 1.0× 1.3k 1.5× 193 0.2× 103 10.0k
Erik A.C. Wiemer 4.8k 1.1× 2.4k 0.8× 458 0.4× 240 0.3× 350 0.4× 158 8.2k
Keith D. Robertson 10.8k 2.5× 1.9k 0.6× 2.2k 2.1× 258 0.3× 717 0.9× 130 13.5k
Simon J. Foote 2.5k 0.6× 930 0.3× 1.4k 1.4× 731 0.8× 257 0.3× 143 7.7k
Wei Wang 5.0k 1.2× 2.7k 0.9× 640 0.6× 189 0.2× 610 0.7× 403 10.5k
Víctor E. Márquez 12.2k 2.9× 1.8k 0.6× 954 0.9× 2.4k 2.7× 332 0.4× 412 16.6k

Countries citing papers authored by Zuben E. Sauna

Since Specialization
Citations

This map shows the geographic impact of Zuben E. Sauna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuben E. Sauna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuben E. Sauna more than expected).

Fields of papers citing papers by Zuben E. Sauna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuben E. Sauna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuben E. Sauna. The network helps show where Zuben E. Sauna may publish in the future.

Co-authorship network of co-authors of Zuben E. Sauna

This figure shows the co-authorship network connecting the top 25 collaborators of Zuben E. Sauna. A scholar is included among the top collaborators of Zuben E. Sauna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuben E. Sauna. Zuben E. Sauna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jankowski, Wojciech, et al.. (2024). Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature Communications. 15(1). 3912–3912. 3 indexed citations
2.
Lagassé, H. A. Daniel, et al.. (2024). Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16+ NK cell activation. Frontiers in Immunology. 15. 1341013–1341013. 1 indexed citations
4.
Jankowski, Wojciech, et al.. (2023). The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity. Frontiers in Immunology. 14. 1271120–1271120. 4 indexed citations
5.
Xiao, Jerry, Joseph R. McGill, Kelly Stanton, et al.. (2020). Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis. Cancers. 12(10). 2784–2784. 17 indexed citations
6.
Yoğurtçu, Osman N., Zuben E. Sauna, Joseph R. McGill, Million A. Tegenge, & Hong Yang. (2019). TCPRO: An In-Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity. Biophysical Journal. 116(3). 563a–563a. 3 indexed citations
7.
Yoğurtçu, Osman N., Zuben E. Sauna, Joseph R. McGill, Million A. Tegenge, & Hong Yang. (2019). TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity. The AAPS Journal. 21(5). 96–96. 15 indexed citations
8.
Sarachana, Tewarit, Neetu Dahiya, Vijaya L. Simhadri, et al.. (2015). Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene. PLoS ONE. 10(7). e0132433–e0132433. 18 indexed citations
9.
Sauna, Zuben E., et al.. (2014). Pharmacogenetics and the Immunogenicity of Protein Therapeutics. Journal of Interferon & Cytokine Research. 34(12). 931–937. 11 indexed citations
10.
Howard, Tom E., et al.. (2013). Detection of Intracellular Factor VIII Protein in Peripheral Blood Mononuclear Cells by Flow Cytometry. BioMed Research International. 2013. 1–8. 9 indexed citations
11.
Hoinka, Jan, Elena Zotenko, Adam Friedman, Zuben E. Sauna, & Teresa M. Przytycka. (2012). Identification of sequence–structure RNA binding motifs for SELEX-derived aptamers. Bioinformatics. 28(12). i215–i223. 77 indexed citations
12.
Bhatnagar, Jaya, Hong‐May Sim, Elka R. Georgieva, et al.. (2012). Mapping Conformational Changes Associated with the Catalytic Cycle of Human P-Glycoprotein (ABCB1). Biophysical Journal. 102(3). 606a–607a. 1 indexed citations
13.
Zichel, Ran, et al.. (2012). Aptamers as a Sensitive Tool to Detect Subtle Modifications in Therapeutic Proteins. PLoS ONE. 7(2). e31948–e31948. 34 indexed citations
14.
Sauna, Zuben E., Chava Kimchi‐Sarfaty, Suresh V. Ambudkar, & Michael M. Gottesman. (2007). Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer. Cancer Research. 67(20). 9609–9612. 194 indexed citations
15.
Kimchi‐Sarfaty, Chava, Jung Mi Oh, In‐Wha Kim, et al.. (2006). A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity. Science. 315(5811). 525–528. 1912 indexed citations breakdown →
16.
Sauna, Zuben E., Suneet Shukla, & Suresh V. Ambudkar. (2005). Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. Molecular BioSystems. 1(2). 127–134. 78 indexed citations
18.
Sauna, Zuben E., Krishnamachary Nandigama, & Suresh V. Ambudkar. (2004). Multidrug Resistance Protein 4 (ABCC4)-mediated ATP Hydrolysis. Journal of Biological Chemistry. 279(47). 48855–48864. 46 indexed citations
19.
Shukla, Suneet, Zuben E. Sauna, Rajendra Prasad, & Suresh V. Ambudkar. (2004). Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans. Biochemical and Biophysical Research Communications. 322(2). 520–525. 41 indexed citations
20.
Ambudkar, Suresh V., Chava Kimchi‐Sarfaty, Zuben E. Sauna, & Michael M. Gottesman. (2003). P-glycoprotein: from genomics to mechanism. Oncogene. 22(47). 7468–7485. 873 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026